en-es
en-fr
en-sl
en
0.25
0.5
0.75
1.25
1.5
1.75
2
Reduction of Healthcare-Associated Infections by Using Biocidal Copper Oxide Impregnated Linens
Published on Mar 28, 2018842 Views
Related categories
Chapter list
Reduction of Healthcare- Associated Infections by Using Biocidal Copper Oxide Impregnated Linens00:00
Healthcare Associated Infections (HAIs)00:13
Environmental Contamination01:23
Persistence of bacteria on dry inanimate surfaces01:46
What surfaces are most contaminated?02:06
Biocidal Surfaces02:44
Copper - A Wide Spectrum Biocide02:54
Copper Biocidal Mechanism03:15
Metallic Copper – a Biocidal Surface03:54
Biocidal Copper Hard Surfaces04:46
Reduction of HAI and Copper05:23
Copper Oxide – More Potent Biocide05:47
Copper Oxide Biocidal Products06:42
Manufacturing Process07:27
Wide Spectrum Antifungal, Antibacterial and Antiviral Efficacy08:37
Inclusion into Hard Surfaces09:00
Testing by Independent Lab – using GLP09:21
Hospital Solid Biocidal Surfaces09:57
Clinical Setting Results (total bacteria)11:17
Linens, Gowns, Most Contaminated Surfaces11:37
Bacteria Survive for Months on Textiles12:17
Linens as a Source of Nosocomial Pathogens12:35
Bedmaking and Bacteria Spread13:32
Linens & Transmission of Pathogens14:00
Hospital textiles as a source of infection of patients15:28
Hospital textiles as a source of infection of workers15:43
Inclusion of copper oxide into textiles15:54
No decrease in biocidal efficacy with washing16:41
Does use of biocidal textiles reduce HAIs?17:07
Clinical Trial 1 - Chronic Care - Head Injury Ward17:25
Reduction of HAIs – Clinical Trial 1 - 118:27
Reduction of HAIs – Clinical Trial 1 - 218:56
General Design – Chronic Care – Clinical Trial 219:18
Reduction of HAIs – Clinical Trial 2 - 120:32
Reduction of HAIs – Clinical Trial 2 - 220:46
Clinical Trial 3 - Comparison between 2 Acute Care Towers21:02
Reduction of HAIs – Clinical Trial 3 - 122:18
Reduction of HAIs – Clinical Trial 3 - 223:11
Clinical Implementation, USA25:06
Thank you26:26